PubRank

INVEST: INternational VErapamil SR Trandolapril STudy

Clinical Trial ID NCT00133692

PubWeight™ 30.13‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00133692

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006 5.18
2 Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010 5.06
3 Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol 1998 2.62
4 Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease. Circ Cardiovasc Genet 2011 1.69
5 G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension 2012 1.59
6 Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes. Hypertension 2013 1.52
7 KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenet Genomics 2007 1.40
8 Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy. PLoS One 2015 1.38
9 beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Clin Pharmacol Ther 2008 1.37
10 Enhancing clinical trials on the internet: lessons from INVEST. Clin Cardiol 2001 1.31
11 CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circ Cardiovasc Genet 2009 0.94
12 Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics. J Hypertens 2013 0.91
13 Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES). Circ Cardiovasc Genet 2010 0.89
14 Cardiovascular therapies and risk for development of diabetes. J Am Coll Cardiol 2004 0.87
15 Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]). Am J Cardiol 2010 0.84
16 Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation. Pharmacogenomics 2012 0.83
17 Systolic blood pressure and subjective well-being in patients with coronary artery disease. Clin Cardiol 2009 0.83
18 INVEST substudies: design and patient characteristics. Clin Cardiol 2001 0.81
19 Electronic prescribing via the internet for a coronary artery disease and hypertension megatrial. Clin Cardiol 2001 0.80
20 Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension. J Am Heart Assoc 2014 0.79
21 Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes. Pharmacogenet Genomics 2013 0.79
22 The vascular biology of hypertension and atherosclerosis and intervention with calcium antagonists and angiotensin-converting enzyme inhibitors. Clin Cardiol 2001 0.78
23 Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy. BMC Med Res Methodol 2012 0.78
24 Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension. Drugs 2005 0.78
25 Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort. Am J Med 2014 0.77
26 CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril. Eur J Clin Pharmacol 2016 0.77
27 Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort. J Transl Med 2013 0.76
28 Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study. Hypertension 2016 0.76
29 How will INVEST and other hypertension trials change clinical practice? Clin Cardiol 2001 0.76
30 Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST). Clin Cardiol 2013 0.75
31 INVEST: results of combined strategies to control blood pressure. Clin Cardiol 2001 0.75
32 Questions and answers related to the INternational VErapamil SR/trandolapril STudy (INVEST). Clin Cardiol 2001 0.75
33 Characteristics of patients with coronary artery disease and hypertension: a report from INVEST. Clin Cardiol 2001 0.75
Next 100